Increased Expression of Leukocyte Ig-Like Receptor-1 and Activating Role of UL18 in the Response to Cytomegalovirus Infection1

NK and T cells are important for combating CMV infection. Some NK and T cells express leukocyte Ig-like receptor-1 (LIR-1), an inhibitory receptor recognizing MHC class I and the CMV-encoded homolog UL18. We previously demonstrated an early increase in LIR-1-expressing blood lymphocytes in lung-transplanted patients later developing CMV disease. We now show that NK and T cells account for the observed LIR-1 augmentation. Coincubation of PBMC from CMV-seropositive donors with virus-infected lung fibroblasts led to a T cell-dependent secretion of IFN-γ, produced mainly by LIR-1+ T cells and by NK cells. Cytokine production during coculture with fibroblasts infected with virus containing the UL18 gene was augmented compared with the UL18 deletion virus, suggesting a stimulatory role for UL18. However, purified UL18Fc proteins inhibited IFN-γ production of LIR-1+ T cells. We propose that cytokine production in the transplant induces NK and T cells to express LIR-1, which may predispose to CMV disease by MHC/LIR-1-mediated suppression. Although the UL18/LIR-1 interaction could inhibit T cell responses, this unlikely plays a role in response to infected cells. Instead, our data point to an activating role for viral UL18 during infection, where indirect intracellular effects cannot be excluded.

[1]  A. Angulo,et al.  Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. , 2006, Blood.

[2]  Klas Kärre,et al.  Spontaneous mutations in the human CMV HLA class I homologue UL18 affect its binding to the inhibitory receptor LIR‐1/ILT2/CD85j , 2006, European journal of immunology.

[3]  P. Tomasec,et al.  Characterization of a highly glycosylated form of the human cytomegalovirus HLA class I homologue gpUL18. , 2005, The Journal of general virology.

[4]  P. Moss,et al.  Virus-specific cytotoxic T lymphocytes differentially express cell-surface leukocyte immunoglobulin-like receptor-1, an inhibitory receptor for class I major histocompatibility complex molecules. , 2005, The Journal of infectious diseases.

[5]  L. Battini,et al.  Inhibitory Receptors CD85j, LAIR-1, and CD152 Down-Regulate Immunoglobulin and Cytokine Production by Human B Lymphocytes , 2005, Clinical Diagnostic Laboratory Immunology.

[6]  P. Klenerman,et al.  Does memory improve with age? CD85j (ILT‐2/LIR‐1) expression on CD8+ T cells correlates with ‘memory inflation’ in human cytomegalovirus infection , 2005, Immunology and cell biology.

[7]  J. Lieberman,et al.  Increased expression of the natural killer cell inhibitory receptor CD85j/ILT2 on antigen‐specific effector CD8 T cells and its impact on CD8 T‐cell function , 2004, Immunology.

[8]  E. Mocarski Immune escape and exploitation strategies of cytomegaloviruses: impact on and imitation of the major histocompatibility system , 2004, Cellular microbiology.

[9]  S. Pileri,et al.  Specific Recognition of the Viral Protein UL18 by CD85j/LIR-1/ILT2 on CD8+ T Cells Mediates the Non-MHC-Restricted Lysis of Human Cytomegalovirus-Infected Cells1 , 2004, The Journal of Immunology.

[10]  C. Ahn,et al.  Human cytomegalovirus UL18 alleviated human NK-mediated swine endothelial cell lysis. , 2004, Biochemical and biophysical research communications.

[11]  Mikael Eriksson,et al.  Effects of Human Cytomegalovirus Infection on Ligands for the Activating NKG2D Receptor of NK Cells: Up-Regulation of UL16-Binding Protein (ULBP)1 and ULBP2 Is Counteracted by the Viral UL16 Protein1 , 2003, The Journal of Immunology.

[12]  S. Olofsson,et al.  LIR-1 expression on lymphocytes, and cytomegalovirus disease in lung-transplant recipients , 2003, The Lancet.

[13]  Christine A. Biron,et al.  Coordinated and Distinct Roles for IFN-αβ, IL-12, and IL-15 Regulation of NK Cell Responses to Viral Infection1 , 2002, The Journal of Immunology.

[14]  L. Lanier,et al.  Direct Recognition of Cytomegalovirus by Activating and Inhibitory NK Cell Receptors , 2002, Science.

[15]  T. Schall,et al.  Potent Immunosuppressive Activities of Cytomegalovirus- Encoded Interleukin-10 , 2002, Journal of Virology.

[16]  S. Bruno,et al.  Dual Effect of CD85/Leukocyte Ig-Like Receptor-1/Ig-Like Transcript 2 and CD152 (CTLA-4) on Cytokine Production by Antigen-Stimulated Human T Cells1 , 2002, The Journal of Immunology.

[17]  H. Browne,et al.  Human Cytomegalovirus (HCMV)‐Infected Endothelial Cells and Macrophages are Less Susceptible to Natural Killer Lysis Independent of the Downregulation of Classical HLA Class I Molecules or Expression of the HCMV Class I Homologue, UL18 , 2002, Scandinavian journal of immunology.

[18]  B. Alexander,et al.  Infectious complications of lung transplantation , 2001, Transplant infectious disease : an official journal of the Transplantation Society.

[19]  L. Moretta,et al.  Differential disappearance of inhibitory natural killer cell receptors during HAART and possible impairment of HIV-1-specific CD8 cytotoxic T lymphocytes , 2001, AIDS.

[20]  Jonathan W. Heusel,et al.  Vital Involvement of a Natural Killer Cell Activation Receptor in Resistance to Viral Infection , 2001, Science.

[21]  P. Parham,et al.  Differential Expression of Leukocyte Receptor Complex-Encoded Ig-Like Receptors Correlates with the Transition from Effector to Memory CTL1 , 2001, The Journal of Immunology.

[22]  S. Riddell,et al.  Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells , 2001, Nature Immunology.

[23]  C. Hunter,et al.  Bystander Activation of CD8+ T Cells Contributes to the Rapid Production of IFN-γ in Response to Bacterial Pathogens1 , 2001, The Journal of Immunology.

[24]  G. Anastasi,et al.  The CD85/LIR-1/ILT2 Inhibitory Receptor Is Expressed by All Human T Lymphocytes and Down-Regulates Their Functions1 , 2000, The Journal of Immunology.

[25]  D. Cosman,et al.  LIRs/ILTs/MIRs, inhibitory and stimulatory Ig-superfamily receptors expressed in myeloid and lymphoid cells. , 2000, Cytokine & growth factor reviews.

[26]  I. T. Ten Berge,et al.  Development of virus-specific CD4(+) T cells during primary cytomegalovirus infection. , 2000, The Journal of clinical investigation.

[27]  P. Bjorkman,et al.  The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. , 1999, Immunity.

[28]  D. Neau,et al.  Evaluation of New Quantitative Assays for Diagnosis and Monitoring of Cytomegalovirus Disease in Human Immunodeficiency Virus-Positive Patients , 1999, Journal of Clinical Microbiology.

[29]  C. Maliszewski,et al.  The MHC class I binding proteins LIR‐1 and LIR‐2 inhibit Fc receptor‐mediated signaling in monocytes , 1998, European journal of immunology.

[30]  S. Jonjić,et al.  Hierarchical and Redundant Lymphocyte Subset Control Precludes Cytomegalovirus Replication during Latent Infection , 1998, The Journal of experimental medicine.

[31]  P. Bjorkman,et al.  Modulation of Natural Killer Cell Cytotoxicity in Human Cytomegalovirus Infection: The Role of Endogenous Class I Major Histocompatibility Complex and a Viral Class I Homolog , 1998, The Journal of experimental medicine.

[32]  U. Koszinowski,et al.  Immune evasion by cytomegalovirus--survival strategies of a highly adapted opportunist. , 1998, Trends in microbiology.

[33]  P. Bjorkman,et al.  Characterization of a Murine Cytomegalovirus Class I Major Histocompatibility Complex (MHC) Homolog: Comparison to MHC Molecules and to the Human Cytomegalovirus MHC Homolog , 1998, Journal of Virology.

[34]  M. Colonna,et al.  A Common Inhibitory Receptor for Major Histocompatibility Complex Class I Molecules on Human Lymphoid and Myelomonocytic Cells , 1997, The Journal of experimental medicine.

[35]  M. Kubin,et al.  A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. , 1997, Immunity.

[36]  O. Mandelboim,et al.  The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells , 1997, Nature.

[37]  J. Orange,et al.  Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration , 1995, The Journal of experimental medicine.

[38]  S. Jonjić,et al.  Restoration of cytomegalovirus antigen presentation by gamma interferon combats viral escape , 1994, Journal of virology.

[39]  H. Einsele,et al.  Practices for cytomegalovirus diagnosis, prophylaxis and treatment in allogeneic bone marrow transplant recipients: a report from the Working Party for Infectious Diseases of the EBMT. , 1993, Bone marrow transplantation.

[40]  J. Grundy,et al.  Up-regulation of LFA-3 and ICAM-1 on the surface of fibroblasts infected with cytomegalovirus. , 1993, Immunology.

[41]  H. Browne,et al.  Construction and characterization of a human cytomegalovirus mutant with the UL18 (class I homolog) gene deleted , 1992, Journal of virology.

[42]  E. Clark,et al.  Soluble forms of CD40 inhibit biologic responses of human B cells. , 1992, Journal of immunology.

[43]  S. Riddell,et al.  Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. , 1991, Blood.

[44]  S. Beck,et al.  A complex between the MHC class I homologue encoded by human cytomegalovirus and β2 microglobulin , 1990, Nature.

[45]  A. Scalzo,et al.  Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen , 1990, The Journal of experimental medicine.

[46]  J L Sullivan,et al.  Severe herpesvirus infections in an adolescent without natural killer cells. , 1989, The New England journal of medicine.

[47]  S. Beck,et al.  Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens , 1988, Nature.

[48]  L. French,et al.  Plaque Assay of Cytomegalovirus Strains of Human Origin , 1970, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.